dismiss

Clean Sweep Live Auction on Thur. March 28th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

More Industry Headlines

New approach identifies lung cancer patients most likely to respond to chemotherapy Combines radiomics and CT image assessment

3D mammography helps avoid unnecessary breast biopsies, says study 33 percent difference in biopsy rate compared to standard mammography

Mentice partners with RAD-AID to bring interventional radiology training to underserved communities Providing simulator software, hardware and expertise

Apple study suggests wearable technology may be useful in detecting atrial fibrillation May assist in stroke and hospitalization prevention

Nvidia unveils Clara AI platform at GPU Technology Conference Equipped with 13 state-of-the-art classification and segmentation algorithms

Solving the Rubik’s Cube of payer data Understanding and recognizing the patterns that lead to success

National Mobile X-ray acquires MMDS Mobile X-ray Expands reach deeper in southeastern US

Echocardiogram should play role in patient selection for transcatheter mitral valve repair, says study New study highlighted at ACC

Building a health data utility: Three secrets to a fresh model for interoperability Teaching healthcare how to share

FDA gives green light for smallest, slimmest 3T CRM devices Extended battery lives, greater diagnostic and therapeutic capabilities

Courtesy of Olympus

Olympus' imaging technology for bladder biopsies gets FDA nod

by Lauren Dubinsky , Senior Reporter
Olympus announced yesterday that its Narrow Band Imaging (NBI) technology received 510(k) clearance from the FDA. NBI will allow physicians to remove small tumors in their offices, which will prevent costly operating room procedures if the tumor is spotted early enough.

The company claims that it's the only patented endoscopic light technology that requires no dyes or drugs to effectively target bladder biopsies that were previously not seen under white light.

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510



Blood absorbs NBI's blue and green light more so it makes the tissue appear darker and allows the surgeon to see vascular structures on the mucosal surface more clearly. The blue light is used to highlight the shallow capillaries and the green light highlights deeper veins.

FDA-reviewed studies found that NBI can visualize 17 percent more Non-Muscle-Invasive Bladder Cancer lesions, 24 percent additional tumors and 28 percent additional carcinoma in situ, which are flat lesions that are hard to detect, than white light.

Bladder cancer is the sixth most prevalent cancer in the U.S., according to the Surveillance, Epidemiology, and End Results Program. In addition, a study published in the World Journal of Urology in 2009 found that it's associated with the highest lifetime treatment costs per patient.

In addition to physicians' offices, NBI can also be used in the operating room or ambulatory surgical center to improve the removal of a tumor. Before removal, the surgeon uses it to target the biopsy and then during removal it improves visibility of tumor margins.

Olympus also developed a NBI urology application for physicians to be used on mobile devices. It includes the technology overview, 28 clinical case images, comparisons of white light and NBI images, an interactive slider and an option to email a case summary to a consulting physician, staff member or patient.

Other than urology, NBI also has implications for gastroenterology and pulmonary and rhinolaryngology. To date, Olympus has FDA approval to screen and monitor Barrett's esophagus, and they are investigating other applications for NBI in gynecology and general surgery.

Related:


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED